BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24448291)

  • 21. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK; Sandooram D; Prinsley PR
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome.
    Suryanarayanan R; Srinivasan VR; O'Sullivan G
    J Laryngol Otol; 2009 Jan; 123(1):45-9. PubMed ID: 18533050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease.
    Longridge NS; Mallinson AI
    J Otolaryngol; 2000 Feb; 29(1):35-9. PubMed ID: 10709170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B; Ozgirgin N; Ozlüoğlu LN
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory.
    Banerjee AS; Johnson IJ
    J Laryngol Otol; 2006 Oct; 120(10):827-31. PubMed ID: 16707038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the round window microcatheter in the treatment of Meniere's disease.
    Hoffer ME; Kopke RD; Weisskopf P; Gottshall K; Allen K; Wester D; Balaban C
    Laryngoscope; 2001 Nov; 111(11 Pt 1):2046-9. PubMed ID: 11801994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M; Marsan J; Schramm D; Robichaud J
    J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis.
    Chia SH; Gamst AC; Anderson JP; Harris JP
    Otol Neurotol; 2004 Jul; 25(4):544-52. PubMed ID: 15241234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
    Martin E; Perez N
    Otol Neurotol; 2003 Sep; 24(5):800-6. PubMed ID: 14501459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of gentamicin inner ear perfusion in Ménière's disease.
    Suryanarayanan R; Cook JA
    J Laryngol Otol; 2004 Jul; 118(7):489-95. PubMed ID: 15318953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
    Gabra N; Saliba I
    Otolaryngol Head Neck Surg; 2013 Apr; 148(4):642-7. PubMed ID: 23314159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective Window Application of Gentamicin+ Dexamethasone in Meniere's Disease.
    Ardıç FN; Tümkaya F; Aykal K; Çabuk B
    J Int Adv Otol; 2017 Aug; 13(2):243-246. PubMed ID: 28716762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratympanic gentamicin for Menière's disease: a meta-analysis.
    Cohen-Kerem R; Kisilevsky V; Einarson TR; Kozer E; Koren G; Rutka JA
    Laryngoscope; 2004 Dec; 114(12):2085-91. PubMed ID: 15564826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intratympanic gentamicin in Menière's disease].
    Huang W; Xu H; Gao B
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease.
    De Stefano A; Dispenza F; De Donato G; Caruso A; Taibah A; Sanna M
    Am J Otolaryngol; 2007; 28(5):289-93. PubMed ID: 17826528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.